Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Megan E. Tesch, Medical oncologist at Dana-Farber Cancer Institute, shared on X:

“What are the clinical implications of incomplete ovarian function suppression? In this study we evaluate estrogen levels in young patients on OFS treatment for breast cancer with ultrasensitive assays and correlate with outcomes.

‘Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy‘

Authors: Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, Philip D. Poorvu, Kathryn J. Ruddy, Rulla Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia Borges, Steven E. Come, Craig Snow, Shalender Bhasin Ann H. Partridge.⁦”

Source: Megan E. Tesch/X